NeuroOne Medical Technologies Corp. (NMTC), a company specializing in neurological surgical care, Friday has priced an underwritten public offering of 16 million common stock shares at $0.50 per share, with Ladenburg Thalmann & Co. Inc. is managing the offering.
The company has granted the underwriter a 45-day option to purchase an additional 2.4 million shares. Gross proceeds are expected to be $8 million, excluding underwriting fees and expenses, with funds allocated for general working capital.
The offering is set to close on April 7, 2025.
NMTC is currently trading at $0.4899 or 43.0349% lower on the Nasdaq Capital Market.
For comments and feedback: editorial@rttnews.com